Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
amyotrophic lateral sclerosis
MedTech
Thermo Fisher debuts protein panel for neurodegeneration R&D
The addition of the multiplex immunoassay panel to the company’s Target 48 proteomics line follows last year’s $3.1 billion acquisition of Olink.
Conor Hale
Sep 16, 2025 12:00pm
After delay, Coya receives FDA go-ahead for phase 2 ALS trial
Aug 25, 2025 11:04am
Another biotech hit with FDA delay for ALS asset
Aug 18, 2025 11:01am
Synchron links BCI device to iPad through new Apple protocol
Aug 4, 2025 11:30am
FDA delays hit clinical trial launch decisions
Jul 30, 2025 10:29am
Corcept unveils promising survival data from phase 2 ALS fail
Jun 5, 2025 8:21am
